Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMARCH: 16S rRNA Sequencing of Healthy Oral Microbiota
NCT07570927Completed
- Sponsor
- Masaryk University
- Start
- Apr 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of chlorhexidine in gingivitis and dental plaque, sponsored by Masaryk University. Primary endpoints: Salivary Microbial Alpha Diversity (Shannon and Simpson Indices) at 24 weeks and Salivary Microbial Beta Diversity (Community Structure) at 24 weeks. Started Apr 2022; status: completed.
02
Drugs
chlorhexidine
03
Conditions
gingivitisdental plaque
Beyond the preview
Go deeper on NCT07570927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07570927.